Evidence map›Paper›PMID 40605410›Full record

ReviewBritish journal of haematology2025

Is it time to offer routine screening for iron deficiency in healthy adolescent females?

Shoshana Revel-Vilk, Tal Ben-Ami, Naama Constantini

Abstract readReview
In one paragraph

Review in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shoshana Revel-VilkPediatric Hematology/Oncology Unit and Gaucher Unit, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID https://orcid.org/0000-0001-9151-0337
Tal Ben-AmiFaculty of Medicine, Hebrew University, Jerusalem, Israel.
Naama ConstantiniFaculty of Medicine, Hebrew University, Jerusalem, Israel.ORCID https://orcid.org/0000-0002-5480-0180

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron deficiency (ID), with or without anaemia, remains a significant global health issue among adolescents. Despite its high prevalence and impact on physical and cognitive function, ID is often underrecognized and undertreated. Adolescent females are particularly at risk due to dietary patterns and menstrual blood loss. Serum ferritin is the most reliable marker of iron status. However, its interpretation and the effect of inflammation should be acknowledged. Current screening practices often focus only on individuals with symptoms or known risk factors. This paper challenges that approach and supports universal screening using haemoglobin and ferritin testing in female adolescents around the age of 14-15, approximately 3 years post-menarche. Improving detection requires making screening more accessible, adolescent-friendly and connected to timely follow-up care. The end result is to build a healthier adolescent female population, preparing them to become healthier adult women facing the challenges of women's manifold roles in the modern world. It is important to clarify that the value of eliminating ID extends beyond future pregnancy readiness; it is equally critical for supporting the cognitive, physical and social demands of everyday life faced by adolescent girls and young women.

Indexed as

Anemia, Iron-DeficiencyIron DeficienciesMass ScreeningAdolescentFemaleFerritinsHemoglobinsHumansIronFerritinsHemoglobinsIronadolescent femalesanaemiairon deficiencypublic healthscreening

Identifiers

PMID40605410
PMCPMC12512079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.